Perioperative cardiovascular risk stratification has traditionally centered on left ventricular ejection fraction, but recent clinical literature has increasingly questioned whether this conventional metric alone effectively determines surgical vulnerability. In a perspective published in the journal Perioperative Medicine, researcher Maria Giulia Bellicini argues that categorization based solely on ejection fraction fails to capture the true drivers of clinical outcomes in surgical patients presenting with heart failure with preserved ejection fraction.
The published analysis highlights that acute heart failure appears relatively uncommon among surgical patients with preserved left ventricular ejection fraction unless specific, identifiable major structural or hemodynamic dysfunctions are already present before intervention. These critical pre-existing conditions include severe valvular disease, precapillary pulmonary hypertension accompanied by cor pulmonale, restrictive cardiomyopathies, or terminal renal disease.
When these severe structural and hemodynamic abnormalities are absent, the diagnostic label of heart failure with preserved ejection fraction frequently describes a heterogeneous clinical syndrome rather than a uniform disease entity. Rather than denoting an intrinsic cardiac phenotype inherently prone to sudden acute decompensation, this clinical condition is often dominated by exertional dyspnea driven substantially by significant extracardiac and peripheral physiological contributors across diverse surgical populations.
Consequently, perioperative vulnerability observed in these surgical candidates may primarily reflect the cumulative systemic impact of advanced age, an extensive burden of extracardiac comorbidities, underlying pulmonary or renal disease, and generalized multisystem frailty.
Because traditional ejection fraction categories overlook these complex systemic interactions, the perspective advocates for transitioning toward a physiology-guided perioperative assessment framework. Such an approach systematically integrates the detailed evaluation of identifiable structural abnormalities, pulmonary pressures, clinical congestion, and right ventricular function.
Importantly, the perspective clarifies that moving beyond left ventricular ejection fraction does not diminish the well-established prognostic significance of exertional dyspnea, elevated natriuretic peptides, or general perioperative fragility.
According to the analysis, routinely monitored clinical indicators—including circulating biomarkers, objective congestion indices, pulmonary pressures, and venous Doppler ultrasound findings—may largely reflect the overall severity of systemic illness, extracardiac frailty, or alternative cardiac pathologies.
Moving forward, the author emphasizes that future perioperative studies must critically reconsider whether existing definitions of heart failure with preserved ejection fraction adequately distinguish true cardiac decompensation from heterogeneous syndromes of aging, vascular congestion, pulmonary vascular disease, and multisystem frailty.
Subject of Research: Perioperative cardiovascular risk stratification in heart failure with preserved ejection fraction
Article Title: HFpEF in perioperative medicine
Article References: Bellicini, M. G. (2026). HFpEF in perioperative medicine. Perioperative Medicine, 15(1), Article 78. https://doi.org/10.1186/s13741-026-00702-4
Image Credits: AI Generated
DOI: 10.1186/s13741-026-00702-4
Keywords: perioperative medicine, heart failure, HFpEF, left ventricular ejection fraction, LVEF, acute heart failure, cardiovascular risk stratification, valvular disease, pulmonary hypertension, cor pulmonale, restrictive cardiomyopathy, renal disease, multisystem frailty, pulmonary pressure, right ventricular function, natriuretic peptides, venous Doppler, exertional dyspnea
News Source: Ophelia Keating. (November 19, 2026). Physiology Guided Assessment Challenges Ejection Fraction in Perioperative Heart Failure. Scienmag.



